Pharmeco Group is a vertically integrated holding company operating in all segments of the pharmaceutical market: research and development, production and distribution of drugs, medical equipment and other medicinal products.
This year we are interested in participating in the session "Innovation in Pharma: Achieving Sovereignty but Not Churning Out Generics", a session of Kommersant Publishing House at BIOPROM-2024.
As Pharmeco is constantly evolving, we, like many large Russian pharmaceutical companies, have been thinking about incorporating innovations into our programme portfolio. In this regard, it would be interesting for us to share experiences with our colleagues and other stakeholders, discuss the main pitfalls and look for possible solutions together.
This year we are interested in participating in the session "Innovation in Pharma: Achieving Sovereignty but Not Churning Out Generics", a session of Kommersant Publishing House at BIOPROM-2024.
As Pharmeco is constantly evolving, we, like many large Russian pharmaceutical companies, have been thinking about incorporating innovations into our programme portfolio. In this regard, it would be interesting for us to share experiences with our colleagues and other stakeholders, discuss the main pitfalls and look for possible solutions together.